AChE antisense oligonucleotide as an anti-inflammatory agent

Hermona Soreq; Amir Dori; Itzhak Wirguin; Gal Ifergane; Raz Yirmiya

AChE antisense oligonucleotide as an anti-inflammatory agent

Hermona Soreq (Inventor)
, Amir Dori (Inventor)
, Itzhak Wirguin (Inventor)
, Gal Ifergane (Inventor)
, Raz Yirmiya (Inventor)

Research output: Patent

Abstract

Disclosed is a novel use for AChE antisense oligonucleotides as anti-inflammatory agents, wherein said oligonucleotides are preferably as denoted by SEQ ID NO:1, SEQ ID NO:2 and SEQ ID NO:7. Methods of treatment of inflammatory conditions, as well as fever, and particularly inflammation-associated neuropathies such as Guillain-Barré Syndrome, are described.

Original language	American English
Patent number	US2009005331
IPC	A61P 29/ 00 A I
Priority date	18/04/07
State	Published - 1 Jan 2009

Cite this

@misc{6b0df7c6c0694c7097d9eccfed809035,

title = "AChE antisense oligonucleotide as an anti-inflammatory agent",

abstract = "Disclosed is a novel use for AChE antisense oligonucleotides as anti-inflammatory agents, wherein said oligonucleotides are preferably as denoted by SEQ ID NO:1, SEQ ID NO:2 and SEQ ID NO:7. Methods of treatment of inflammatory conditions, as well as fever, and particularly inflammation-associated neuropathies such as Guillain-Barr{\'e} Syndrome, are described.",

author = "Hermona Soreq and Amir Dori and Itzhak Wirguin and Gal Ifergane and Raz Yirmiya",

year = "2009",

month = jan,

day = "1",

language = "American English",

type = "Patent",

note = "US2009005331; A61P 29/ 00 A I",

}

TY - PAT

T1 - AChE antisense oligonucleotide as an anti-inflammatory agent

AU - Soreq, Hermona

AU - Dori, Amir

AU - Wirguin, Itzhak

AU - Ifergane, Gal

AU - Yirmiya, Raz

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Disclosed is a novel use for AChE antisense oligonucleotides as anti-inflammatory agents, wherein said oligonucleotides are preferably as denoted by SEQ ID NO:1, SEQ ID NO:2 and SEQ ID NO:7. Methods of treatment of inflammatory conditions, as well as fever, and particularly inflammation-associated neuropathies such as Guillain-Barré Syndrome, are described.

AB - Disclosed is a novel use for AChE antisense oligonucleotides as anti-inflammatory agents, wherein said oligonucleotides are preferably as denoted by SEQ ID NO:1, SEQ ID NO:2 and SEQ ID NO:7. Methods of treatment of inflammatory conditions, as well as fever, and particularly inflammation-associated neuropathies such as Guillain-Barré Syndrome, are described.

M3 - Patent

M1 - US2009005331

ER -

AChE antisense oligonucleotide as an anti-inflammatory agent

Abstract

Fingerprint

Cite this